We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+6.77%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$28.6B
AUM Growth
-$18.3M
Cap. Flow
-$1.63B
Cap. Flow %
-5.69%
Top 10 Hldgs %
43.66%
Holding
291
New
10
Increased
60
Reduced
140
Closed
13

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$45.6M
2
AZN icon
AstraZeneca
AZN
+$37.9M
3
EOG icon
EOG Resources
EOG
+$23.4M
4
UNH icon
UnitedHealth
UNH
+$20.1M
5
LLY icon
Eli Lilly
LLY
+$14.2M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$152M
2
PG icon
Procter & Gamble
PG
+$129M
3
BNY
Bank of New York Mellon
BNY
+$128M
4
AAPL icon
Apple
AAPL
+$123M
5
CVX icon
Chevron
CVX
+$112M

Sector Composition

Rank Sector Weight
1 Technology 25.27%
2 Financials 17.16%
3 Consumer Staples 16.61%
4 Energy 11.67%
5 Healthcare 11.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMP icon
176
Ameriprise Financial
AMP
$48.3B
$820K ﹤0.01%
2,470
FOX icon
177
Fox Class B
FOX
$21.8B
$781K ﹤0.01%
24,482
-28,449
-54% -$862K
KEX icon
178
Kirby Corp
KEX
$7.01B
$777K ﹤0.01%
10,097
-10,098
-50% -$727K
ADM icon
179
Archer Daniels Midland
ADM
$38.2B
$773K ﹤0.01%
10,234
GILD icon
180
Gilead Sciences
GILD
$162B
$754K ﹤0.01%
9,785
-35,009
-78% -$2.79M
BDX icon
181
Becton Dickinson
BDX
$45.6B
$754K ﹤0.01%
2,856
-1
-0% -$254
HWC icon
182
Hancock Whitney
HWC
$6.2B
$732K ﹤0.01%
19,062
POOL icon
183
Pool Corp
POOL
$6.75B
$729K ﹤0.01%
1,946
+400
+26% +$137K
RL icon
184
Ralph Lauren
RL
$22.6B
$727K ﹤0.01%
5,900
-15,000
-72% -$1.73M
CCK icon
185
Crown Holdings
CCK
$12.8B
$704K ﹤0.01%
8,100
BKNG icon
186
Booking.com
BKNG
$149B
$694K ﹤0.01%
6,425
-350
-5% -$37K
SYK icon
187
Stryker
SYK
$125B
$681K ﹤0.01%
2,232
+308
+16% +$89K
BIIB icon
188
Biogen
BIIB
$30B
$655K ﹤0.01%
2,300
-5,113
-69% -$1.52M
ETN icon
189
Eaton
ETN
$161B
$651K ﹤0.01%
3,237
-55
-2% -$9.67K
BALL icon
190
Ball Corp
BALL
$17.3B
$634K ﹤0.01%
10,900
BAX icon
191
Baxter International
BAX
$13.5B
$624K ﹤0.01%
13,686
-787
-5% -$34.3K
DD icon
192
DuPont de Nemours
DD
$18.5B
$604K ﹤0.01%
6,735
-11,817
-64% -$1.02M
BHP icon
193
BHP
BHP
$215B
$599K ﹤0.01%
10,036
-7,953
-44% -$474K
GS icon
194
Goldman Sachs
GS
$300B
$598K ﹤0.01%
1,855
-78
-4% -$25.6K
SHAK icon
195
Shake Shack
SHAK
$2.53B
$591K ﹤0.01%
7,600
-2,000
-21% -$128K
IRM icon
196
Iron Mountain
IRM
$36.4B
$584K ﹤0.01%
10,274
-512
-5% -$28K
GWW icon
197
W.W. Grainger
GWW
$65.3B
$583K ﹤0.01%
739
PANW icon
198
Palo Alto Networks
PANW
$270B
$581K ﹤0.01%
4,544
VEA icon
199
Vanguard FTSE Developed Markets ETF
VEA
$229B
$575K ﹤0.01%
12,444
DOW icon
200
Dow Inc
DOW
$21.9B
$574K ﹤0.01%
10,783
-14,833
-58% -$788K

Similar funds

Fayez Sarofim & Co's Q2 2023 Portfolio in Review

As of Q2 2023, Fayez Sarofim & Co held 291 positions worth $28.6B, down 0.06% from $28.6B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Fayez Sarofim & Co withdrew a net $1.63B in Q2 2023, closing 13 positions and reducing 140 holdings. Its most notable exit was AvalonBay Communities, an estimated $1.33M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Staples.

Against the trend, Fayez Sarofim & Co opened a new position in iShares Core High Dividend ETF worth $8.67M.

  • Fayez Sarofim & Co's largest Q2 2023 buy was iShares Core High Dividend ETF: 430,000 shares worth $8.67M.
  • Fayez Sarofim & Co added most to CME Group in Q2 2023, an estimated $45.6M increase.
  • Fayez Sarofim & Co's biggest Q2 2023 reduction was Microsoft, cutting an estimated $152M.
  • Fayez Sarofim & Co fully exited AvalonBay Communities in Q2 2023, selling an estimated $1.33M.
  • Fayez Sarofim & Co's ten largest holdings make up 44% of its $28.6B portfolio in Q2 2023.
  • Fayez Sarofim & Co opened 10 new positions and closed 13 in Q2 2023.
  • Fayez Sarofim & Co's portfolio value fell 0.06% quarter-over-quarter to $28.6B.

Based on Fayez Sarofim & Co's 13F filing for Q2 2023, filed 14 Aug 2023.